Lorglumide
Lorglumide is a drug that acts as a Cholecystokinin antagonist. It is primarily used in scientific research to explore the role of Cholecystokinin (CCK) in the body.
Chemistry[edit]
Lorglumide is a synthetic compound. It is classified as a peptide antagonist, meaning it blocks the action of certain peptides in the body. In the case of Lorglumide, the peptide it targets is Cholecystokinin.
Pharmacology[edit]
Lorglumide works by blocking the action of Cholecystokinin, a hormone that stimulates the release of digestive enzymes from the pancreas and bile from the gallbladder. By blocking the action of CCK, Lorglumide can be used to study the role of this hormone in digestion and other physiological processes.
Uses[edit]
The primary use of Lorglumide is in scientific research. It is used to study the role of Cholecystokinin in various physiological processes, including digestion, satiety, and pain perception. Lorglumide has also been used in studies investigating the role of CCK in psychiatric disorders, such as anxiety and depression.
Side Effects[edit]
As a research tool, Lorglumide is not typically used in humans, so its side effect profile is not well known. However, as a CCK antagonist, it could potentially cause digestive issues if used in humans.
See Also[edit]
